Clinical Trials Browser

INDUSTRY × Pancreatic Neoplasms × AZD 6244 × Clear all

NCT00372944 2014-08-13

AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms